A comprehensive approach to HIV/STI prevention in the context of sexual health in the EU/EEA
This report highlights the benefits of a comprehensive approach to disease prevention, integrating HIV and STI control programming in Europe into broader public health strategies. Attempts to prevent HIV and STI among vulnerable groups can be more effective when seen from the context of sexual health and health promotion. This can be achieved by mapping past and current activities and identifying key stakeholders and potential data sources in the European Union and European Economic Area.
This report highlights the benefits of a comprehensive approach to disease prevention, integrating HIV and STI control programming in Europe into broader public health strategies, whilst recognising the linkages between different sexual health outcomes and the overlap and synergy between the interventions required to address HIV/STI and other aspects of sexual health. Groups most vulnerable to infection, including young people, men who have sex with men (MSM), sex workers, migrants, people living with HIV (PLHIV), populations at risk of sexual violence, and people who inject drugs (PWID) experience a range of sexual health needs. Vulnerability among these individuals is determined not only by risk behaviour, such as unprotected sex, but by social structural determinants that can affect access to healthcare and education. As poor sexual health, including HIV and STIs, is a significant cause of morbidity and mortality in Europe, prevention efforts need to be strengthened.
The overall aim of this project was to increase the understanding of how HIV and STI can be prevented among vulnerable groups in the broader context of sexual health and health promotion. This aim was achieved by mapping past and current activities, key stakeholders, and potential data sources in the European Union and European Economic Area (EU/EEA).
EU/EEA capacity for the surveillance of hepatitis B and C using molecular methods
23 Jan 2018 - In order to explore whether the current capacity for EU/EEA-wide molecular characterisation for surveillance of HBV and HCV is sufficient to be feasible and what gaps need to be addressed, a survey of EU/EEA Member States was conducted to assess their laboratory capacity and needs in relation to the molecular characterisation of hepatitis B and C.
European Gonococcal Antimicrobial Surveillance Programme external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing, 2017
27 Oct 2017 - An EQA scheme for antimicrobial susceptibility testing in Neisseria gonorrhoeae has been available to laboratories participating in ECDC’s European Sexually Transmitted Infections (STI) surveillance network since 2010. This is the third EQA to be published on antimicrobial susceptibility testing in Neisseria gonorrhoeae.
Gonococcal antimicrobial susceptibility surveillance in Europe, 2015
24 Aug 2017 - The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) follows a decentralised and centralised testing model. In 2015, 24 EU/EEA Member States participated in Euro-GASP, 17 through decentralised testing.